NHS England takes 40 days to diagnose cancer
A study published in the British Journal of General Practice [...]
Avelumab combination designated a breakthrough therapy by the FDA
The immunotherapy drug avelumab (Bavencio) has been designated a breakthrough [...]
US Food and Drug Administration approves frontline cabozantinib for advanced kidney cancer
Cabozantinib (Cabometyx) has been granted approval by the US Food [...]
Pembrolizumab investigated as adjuvant therapy for renal cell carcinoma
Immunotherapy has been a major breakthrough in the treatment of [...]
European guidelines for the management of metastatic renal cell carcinoma to be updated
The European Association of Urology (EAU) guidelines are to be [...]
Nivolumab-ipilimumab combination granted priority review by FDA
The Food and Drug Adminitration in the US has granted [...]
Management of bone metastases in renal cell carcinoma
The following video from Practise Update is an interview with [...]
Adjuvant therapy for renal cell carcinoma
The following article is a good review of the data [...]
Patients hit by shortages of drugs as prices soar
The Times this week reports that as a result of supply [...]
Positive interim results for atezolizumab plus bevacizumab combination in advanced RCC
Interim results from the phase III IMmotion151 study to assess [...]
